Natalizumab and PML in MS - Introduction
Links shared publicly online about this topic.
- 0total visits
Natalizumab and PML in MS - Introduction
View full resource at medmerits.com
Tags: Tysabri
Most Recently Shared on October 22, 2011 at 8:36 pm By:
@jcberrypdx Detailed scientific article re: Tysabri and PML in MS http://t.co/Vr0NywbT Stats included are from 2009 but good otherwise.
Clinical Neurology News - January 2012 - (12)
nxtbook.com — “Digital Edition” View full resource at nxtbook.com
Most Recently Shared on March 31, 2012 at 2:26 am By:
Jerome P. Lisk, M.D. Doctor, Neurologist, and Physician
MS Activity Returns After Stopping Natalizumab http://t.co/OfzsriaQ
Brass and Ivory: Life with MS & RA: Tysabri-PML Cases as of March 1, 2012
brassandivory.org — “My MS blog talking about life with multiple sclerosis and rheumatoid arthritis while working as a musician in Washington, DC. - Lisa Emrich” View full resource at brassandivory.org
Most Recently Shared on March 22, 2012 at 1:50 am By:
Tysabri-PML Cases as of March 1, 2012: I've been following the reported incidence of cases of progressive multif... http://t.co/k5MOAwpL
FDA identifies new risk factor for PML w/ natalizumab, allowing patients to be risk-stratified; Pg 1. GI & Hep News: http://t.co/luz5Bqu7
gastro.org — “FDA identifies new risk factor for PML w/ natalizumab, allowing patients to be risk-stratified; Pg 1. GI & Hep News: http://t.co/luz5Bqu7” View full resource at gastro.org
Most Recently Shared on March 13, 2012 at 5:50 pm By:
RT @amergastroassn: Metformin use may be associated with lower risk of pancreatic cancer in women, but not men. http://t.co/BSiwiI3D
National MS Society Blog: FDA updates Tysabri label to include testing for PML risk
blog.nationalmssociety.org — “Julie Stachowiak, PhD Writer, ms.about.com The US Food and Drug Administration just approv...” View full resource at blog.nationalmssociety.org
Most Recently Shared on January 24, 2012 at 9:40 pm By:
Julie Stachowiak blogs about what #FDA updates to Tysabri labels mean for people living with #MS. http://t.co/nzjftwDf
Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS
neurology.org — “Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS” View full resource at neurology.org
Most Recently Shared on December 6, 2011 at 8:30 pm By:
Neurology Journal Medical Journal and Neurology
Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS http://t.co/2FbuAU99 #neurology
TYSABRI? Ongoing Research
msrc.co.uk — “Tysabri (Natalizumab) page with information on Tysabri (Natalizumab) and Multiple Sclerosis Research in the MS Research News section of the Multiple Sclerosis Resource Centre (MSRC) website.” View full resource at msrc.co.uk
Most Recently Shared on October 22, 2011 at 8:31 pm By:
@jcberrypdx Press releases re: Tysabri Research can be found at MSRC http://t.co/Py15QLcT (in addition to the link below re: tysabri news)
Brass and Ivory: Life with MS & RA: PML
brassandivory.org — “My MS blog talking about life with multiple sclerosis and rheumatoid arthritis while working as a musician in Washington, DC. - Lisa Emrich” View full resource at brassandivory.org
Most Recently Shared on October 22, 2011 at 8:30 pm By:
@jcberrypdx I keep informal updates on the blog (and include some press releases/articles in DowJones ) re: Tysabri-PML http://t.co/3WfJYxWD
Multiple Sclerosis Research: Natalizumab PML Update - Aug 2011
multiple-sclerosis-research.blogspot.com — “Multiple Sclerosis Research: Natalizumab PML Update - Aug 2011” View full resource at multiple-sclerosis-research.blogspot.com
Most Recently Shared on October 22, 2011 at 8:28 pm By:
@jcberrypdx Nice graphs re: PML risk and JCV status as of Aug update with 159 Tysabri-PML cases http://t.co/erz6XWCj
TYSABRI?
msrc.co.uk — “Tysabri (Natalizumab) Latest News page with information on the latest Tysabri (Natalizumab) news and Multiple Sclerosis Research in the MS Research News section of the Multiple Sclerosis Resource Centre (MSRC) website.” View full resource at msrc.co.uk
Most Recently Shared on October 22, 2011 at 8:25 pm By:
@jcberrypdx Or per 1000: 2.41 (1 yr or longer), 3.03 (2 yrs or longer), 1.85 (3 yrs or longer) http://t.co/CTbizWd7 scroll down to July
Brass and Ivory: Life with MS & RA: Updated Tysabri-PML Cases in September 2011
brassandivory.org — “My MS blog talking about life with multiple sclerosis and rheumatoid arthritis while working as a musician in Washington, DC. - Lisa Emrich” View full resource at brassandivory.org
Most Recently Shared on September 28, 2011 at 2:21 am By:
Lisa: Updated Tysabri-PML Cases in September 2011: Investor outlets must be less and less interested in the grow... http://t.co/fbC1MZqz
Brass and Ivory: Life with MS & RA: Updated Tysabri-PML Cases in September 2011
brassandivory.org — “My MS blog talking about life with multiple sclerosis and rheumatoid arthritis while working as a musician in Washington, DC. - Lisa Emrich” View full resource at brassandivory.org
Most Recently Shared on September 28, 2011 at 1:56 am By:
Updated Tysabri-PML Cases in September 2011: Investor outlets must be less and less interested in the growing nu... http://t.co/Xc9PksJ4
Medical News: AAN: Risk Factors Up PML Risk 70-fold - in Meeting Coverage, AAN from MedPage Today
medpagetoday.com — “HONOLULU -- Nearly one in 100 patients taking natalizumab (Tysabri) with three risk factors -- more than two years on the drug, prior immunosuppressant therapy and positive serology for JC virus infec” View full resource at medpagetoday.com
Most Recently Shared on August 16, 2011 at 7:37 pm By:
Roger D. Jones, PhD PhD, Doctor, Health Executive, and Health Social Media
Medical News: AAN: Risk Factors Up PML Risk 70-fold - in Meeting Coverage, AAN from MedPage Today - http://t.co/id9rDSU from @medpagetoday
Survival in MS-based PML Improves, But Disability Still High (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- Survival has improved dramatically for patients with multiple sclerosis who develop progressive multifocal leukoencephalopathy (PML) during treatment with natalizumab (Tysabri), a study found.” View full resource at qualitypointtech.net
Most Recently Shared on May 22, 2011 at 6:00 pm By:
Survival in MS-based PML Improves, But Disability Still High (CME/CE): (MedPage Today) -- Survival has improved dr... http://bit.ly/mAD2Tr
Medical News: Survival in MS-based PML Improves, But Disability Still High - in Neurology, General Neurology from MedPage Today
medpagetoday.com — “Survival has improved dramatically for patients with multiple sclerosis who develop progressive multifocal leukoencephalopathy (PML) during treatment with natalizumab (Tysabri), a study found.” View full resource at medpagetoday.com
Most Recently Shared on May 22, 2011 at 5:07 pm By:
Survival in MS-based PML Improves, But Disability Still High (CME/CE): (MedPage Today) -- Survival has improved dramat.. http://dld.bz/aaTgx
Medical News: FDA Updates PML Risk Info for Natalizumab - in Neurology, Multiple Sclerosis from MedPage Today
medpagetoday.com — “As expected, the FDA has approved new label language for the multiple sclerosis drug natalizumab (Tysabri) with additional detail on the risks of progressive multifocal leukoencephalopathy (PML).” View full resource at medpagetoday.com
Most Recently Shared on April 22, 2011 at 8:31 pm By:
Thomas Loarie, Jr Health Advocate
@medpagetoday FDA Updates PML Risk Info for Natalizumab http://bit.ly/i6ZA0J #medical #Health
Advertisement
